| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prejudice | 39 | 2019 | 574 | 5.390 |
Why?
|
| Health Status Disparities | 33 | 2023 | 1885 | 4.760 |
Why?
|
| Public Health | 43 | 2024 | 2679 | 3.950 |
Why?
|
| Social Justice | 21 | 2024 | 486 | 3.650 |
Why?
|
| Censuses | 19 | 2023 | 198 | 3.590 |
Why?
|
| Social Class | 47 | 2022 | 2008 | 3.310 |
Why?
|
| Residence Characteristics | 22 | 2024 | 2118 | 3.200 |
Why?
|
| Socioeconomic Factors | 84 | 2024 | 7852 | 3.100 |
Why?
|
| Poverty | 35 | 2020 | 2720 | 2.660 |
Why?
|
| Epidemiology | 13 | 2024 | 278 | 2.610 |
Why?
|
| Epidemiologic Methods | 20 | 2016 | 1328 | 2.080 |
Why?
|
| Police | 6 | 2020 | 158 | 2.040 |
Why?
|
| Income | 19 | 2021 | 1878 | 1.990 |
Why?
|
| Politics | 15 | 2024 | 822 | 1.820 |
Why?
|
| Infant Mortality | 8 | 2019 | 752 | 1.650 |
Why?
|
| Data Collection | 19 | 2021 | 3326 | 1.640 |
Why?
|
| Social Responsibility | 8 | 2024 | 382 | 1.640 |
Why?
|
| Social Conditions | 9 | 2018 | 121 | 1.550 |
Why?
|
| Workplace | 9 | 2022 | 873 | 1.480 |
Why?
|
| Receptors, Estrogen | 8 | 2022 | 2253 | 1.480 |
Why?
|
| Homicide | 4 | 2017 | 294 | 1.470 |
Why?
|
| Mortality | 14 | 2020 | 2911 | 1.430 |
Why?
|
| Law Enforcement | 5 | 2020 | 112 | 1.390 |
Why?
|
| Occupational Exposure | 8 | 2022 | 1807 | 1.350 |
Why?
|
| Educational Status | 19 | 2015 | 2515 | 1.320 |
Why?
|
| United States | 108 | 2024 | 73039 | 1.310 |
Why?
|
| Acidosis | 2 | 2022 | 271 | 1.300 |
Why?
|
| Healthcare Disparities | 11 | 2020 | 3415 | 1.280 |
Why?
|
| Breast Neoplasms | 28 | 2022 | 21207 | 1.220 |
Why?
|
| Premature Birth | 5 | 2023 | 1829 | 1.210 |
Why?
|
| Causality | 10 | 2016 | 1254 | 1.200 |
Why?
|
| Indians, North American | 4 | 2020 | 354 | 1.170 |
Why?
|
| Climate Change | 5 | 2020 | 509 | 1.160 |
Why?
|
| Health Status | 18 | 2011 | 4091 | 1.130 |
Why?
|
| Health Status Indicators | 10 | 2012 | 969 | 1.080 |
Why?
|
| Coronavirus Infections | 6 | 2020 | 3115 | 1.080 |
Why?
|
| Pneumonia, Viral | 6 | 2020 | 3238 | 1.060 |
Why?
|
| Population Surveillance | 15 | 2012 | 2596 | 1.020 |
Why?
|
| Poverty Areas | 4 | 2017 | 268 | 1.010 |
Why?
|
| Social Problems | 3 | 2020 | 108 | 0.990 |
Why?
|
| Humans | 278 | 2024 | 768171 | 0.950 |
Why?
|
| Research | 7 | 2019 | 1979 | 0.940 |
Why?
|
| Mass Media | 2 | 2017 | 303 | 0.940 |
Why?
|
| Violence | 9 | 2020 | 936 | 0.880 |
Why?
|
| Back Injuries | 1 | 2022 | 41 | 0.830 |
Why?
|
| New York City | 8 | 2021 | 737 | 0.800 |
Why?
|
| Social Identification | 2 | 2022 | 108 | 0.800 |
Why?
|
| Terminology as Topic | 9 | 2012 | 1542 | 0.800 |
Why?
|
| Urban Population | 4 | 2019 | 2046 | 0.780 |
Why?
|
| Pandemics | 12 | 2023 | 8747 | 0.770 |
Why?
|
| Gender Identity | 5 | 2021 | 770 | 0.770 |
Why?
|
| Epidemiologic Studies | 6 | 2004 | 677 | 0.770 |
Why?
|
| Family Characteristics | 8 | 2020 | 1003 | 0.760 |
Why?
|
| Epigenomics | 2 | 2024 | 960 | 0.750 |
Why?
|
| Kidney Calculi | 3 | 2021 | 458 | 0.750 |
Why?
|
| Potassium Citrate | 1 | 2021 | 8 | 0.740 |
Why?
|
| Massachusetts | 21 | 2022 | 8890 | 0.730 |
Why?
|
| Military Medicine | 1 | 2022 | 185 | 0.710 |
Why?
|
| Health Surveys | 12 | 2023 | 4057 | 0.700 |
Why?
|
| Local Government | 1 | 2021 | 83 | 0.700 |
Why?
|
| Female | 163 | 2024 | 397187 | 0.690 |
Why?
|
| Epigenesis, Genetic | 2 | 2024 | 3833 | 0.690 |
Why?
|
| SEER Program | 10 | 2022 | 1444 | 0.690 |
Why?
|
| Sex Ratio | 1 | 2020 | 107 | 0.680 |
Why?
|
| Cross-Sectional Studies | 30 | 2024 | 26379 | 0.680 |
Why?
|
| Emigrants and Immigrants | 3 | 2018 | 550 | 0.680 |
Why?
|
| Population Dynamics | 3 | 2021 | 314 | 0.670 |
Why?
|
| Population Groups | 1 | 2020 | 209 | 0.670 |
Why?
|
| Mass Vaccination | 1 | 2021 | 111 | 0.660 |
Why?
|
| Federal Government | 3 | 2020 | 266 | 0.660 |
Why?
|
| Demography | 5 | 2015 | 1641 | 0.640 |
Why?
|
| Adult | 118 | 2024 | 223646 | 0.640 |
Why?
|
| Government | 1 | 2020 | 161 | 0.640 |
Why?
|
| Medically Uninsured | 1 | 2024 | 840 | 0.630 |
Why?
|
| History, 20th Century | 15 | 2019 | 2766 | 0.630 |
Why?
|
| Bone Resorption | 2 | 2020 | 728 | 0.630 |
Why?
|
| Housing | 3 | 2020 | 683 | 0.620 |
Why?
|
| Occupational Health | 6 | 2010 | 812 | 0.620 |
Why?
|
| Employment | 7 | 2011 | 1110 | 0.620 |
Why?
|
| Sexual Harassment | 3 | 2010 | 82 | 0.620 |
Why?
|
| Wills | 1 | 2018 | 13 | 0.610 |
Why?
|
| Models, Theoretical | 7 | 2016 | 3573 | 0.610 |
Why?
|
| Neoplasms | 16 | 2020 | 22371 | 0.610 |
Why?
|
| Social Sciences | 3 | 2005 | 40 | 0.600 |
Why?
|
| Islam | 1 | 2018 | 72 | 0.590 |
Why?
|
| Democracy | 3 | 2020 | 27 | 0.580 |
Why?
|
| Heredity | 1 | 2018 | 149 | 0.580 |
Why?
|
| Earth Sciences | 1 | 2017 | 1 | 0.580 |
Why?
|
| Boston | 18 | 2024 | 9374 | 0.570 |
Why?
|
| Community Health Centers | 3 | 2023 | 469 | 0.570 |
Why?
|
| Death Certificates | 2 | 2017 | 172 | 0.570 |
Why?
|
| Public Health Practice | 4 | 2019 | 221 | 0.570 |
Why?
|
| Data Interpretation, Statistical | 10 | 2016 | 2709 | 0.570 |
Why?
|
| Women's Health | 7 | 2005 | 2082 | 0.570 |
Why?
|
| Health Services Accessibility | 14 | 2019 | 5520 | 0.560 |
Why?
|
| Aging | 6 | 2024 | 8743 | 0.550 |
Why?
|
| Neoplasms, Hormone-Dependent | 2 | 2010 | 410 | 0.550 |
Why?
|
| Middle Aged | 97 | 2024 | 223487 | 0.540 |
Why?
|
| Registries | 13 | 2020 | 8375 | 0.540 |
Why?
|
| Delayed Diagnosis | 1 | 2020 | 467 | 0.530 |
Why?
|
| Political Systems | 2 | 2020 | 23 | 0.510 |
Why?
|
| Male | 130 | 2024 | 364731 | 0.510 |
Why?
|
| Occupations | 9 | 2010 | 516 | 0.510 |
Why?
|
| Infant, Low Birth Weight | 7 | 2023 | 871 | 0.510 |
Why?
|
| Pregnanolone | 6 | 1993 | 67 | 0.500 |
Why?
|
| Osteoblasts | 3 | 2016 | 1153 | 0.500 |
Why?
|
| Health Policy | 9 | 2015 | 2697 | 0.490 |
Why?
|
| Contusions | 1 | 2015 | 78 | 0.490 |
Why?
|
| Ecological and Environmental Phenomena | 1 | 2014 | 10 | 0.490 |
Why?
|
| Population | 2 | 2012 | 141 | 0.480 |
Why?
|
| Menarche | 2 | 2015 | 538 | 0.480 |
Why?
|
| Hypercalciuria | 3 | 2021 | 31 | 0.480 |
Why?
|
| Religion and Psychology | 1 | 2017 | 180 | 0.480 |
Why?
|
| Wounds and Injuries | 3 | 2020 | 2517 | 0.470 |
Why?
|
| Individuality | 3 | 2012 | 307 | 0.470 |
Why?
|
| Olfactory Bulb | 10 | 1989 | 198 | 0.470 |
Why?
|
| Minority Health | 1 | 2015 | 79 | 0.470 |
Why?
|
| Insurance, Health | 4 | 2018 | 2517 | 0.460 |
Why?
|
| Calcium | 5 | 2022 | 5792 | 0.450 |
Why?
|
| Labor Unions | 7 | 2011 | 50 | 0.440 |
Why?
|
| Epidemiologic Research Design | 3 | 2010 | 368 | 0.440 |
Why?
|
| Cause of Death | 5 | 2020 | 3721 | 0.440 |
Why?
|
| Attitude to Health | 6 | 2009 | 2025 | 0.440 |
Why?
|
| Acquired Immunodeficiency Syndrome | 10 | 2000 | 2204 | 0.430 |
Why?
|
| Abortion, Legal | 1 | 2015 | 121 | 0.430 |
Why?
|
| Military Personnel | 1 | 2022 | 1261 | 0.420 |
Why?
|
| Specimen Handling | 1 | 2018 | 707 | 0.420 |
Why?
|
| Public Health Informatics | 2 | 2004 | 109 | 0.420 |
Why?
|
| Firearms | 2 | 2017 | 631 | 0.420 |
Why?
|
| Race Relations | 4 | 2008 | 37 | 0.410 |
Why?
|
| Civil Rights | 1 | 2013 | 131 | 0.410 |
Why?
|
| Soot | 1 | 2014 | 219 | 0.410 |
Why?
|
| Cost of Illness | 3 | 2023 | 1951 | 0.400 |
Why?
|
| Small-Area Analysis | 3 | 2006 | 51 | 0.390 |
Why?
|
| Health Services Research | 5 | 2012 | 1815 | 0.390 |
Why?
|
| History, 19th Century | 7 | 2019 | 714 | 0.390 |
Why?
|
| Social Medicine | 2 | 2003 | 64 | 0.390 |
Why?
|
| Stress, Psychological | 7 | 2012 | 4530 | 0.380 |
Why?
|
| Carbon | 1 | 2015 | 672 | 0.380 |
Why?
|
| Birth Weight | 4 | 2023 | 2121 | 0.380 |
Why?
|
| Vital Statistics | 5 | 2017 | 31 | 0.370 |
Why?
|
| Research Design | 8 | 2012 | 6209 | 0.360 |
Why?
|
| History, 21st Century | 5 | 2019 | 1573 | 0.350 |
Why?
|
| Air Pollutants | 2 | 2015 | 2916 | 0.350 |
Why?
|
| Adolescent | 47 | 2021 | 89169 | 0.350 |
Why?
|
| Tibia | 2 | 2016 | 1076 | 0.340 |
Why?
|
| Geographic Information Systems | 2 | 2021 | 283 | 0.340 |
Why?
|
| Word Association Tests | 1 | 2009 | 52 | 0.340 |
Why?
|
| Privacy | 2 | 2023 | 233 | 0.340 |
Why?
|
| Substance Abuse, Intravenous | 2 | 2005 | 530 | 0.340 |
Why?
|
| Cities | 2 | 2022 | 543 | 0.340 |
Why?
|
| Body Size | 1 | 2012 | 463 | 0.340 |
Why?
|
| Nutrition Surveys | 4 | 2015 | 1738 | 0.330 |
Why?
|
| Aged | 52 | 2024 | 171502 | 0.330 |
Why?
|
| Social Environment | 6 | 2018 | 1012 | 0.330 |
Why?
|
| Infant, Newborn | 18 | 2023 | 26421 | 0.330 |
Why?
|
| Protons | 3 | 2022 | 1113 | 0.330 |
Why?
|
| Homosexuality, Female | 3 | 2015 | 171 | 0.320 |
Why?
|
| Estrogen Replacement Therapy | 2 | 2008 | 1209 | 0.320 |
Why?
|
| Urban Health | 3 | 2017 | 535 | 0.320 |
Why?
|
| Incidence | 18 | 2022 | 21538 | 0.320 |
Why?
|
| DNA Copy Number Variations | 1 | 2018 | 2048 | 0.320 |
Why?
|
| Public Opinion | 2 | 2012 | 486 | 0.320 |
Why?
|
| Smoking | 7 | 2012 | 9092 | 0.320 |
Why?
|
| Osteogenesis | 1 | 2016 | 1295 | 0.310 |
Why?
|
| Morbidity | 3 | 2012 | 1755 | 0.310 |
Why?
|
| Age Factors | 17 | 2020 | 18415 | 0.310 |
Why?
|
| Infant | 18 | 2024 | 36535 | 0.310 |
Why?
|
| Receptors, G-Protein-Coupled | 2 | 2016 | 1247 | 0.310 |
Why?
|
| DNA | 2 | 2022 | 7213 | 0.300 |
Why?
|
| California | 10 | 2009 | 1438 | 0.290 |
Why?
|
| Models, Statistical | 5 | 2021 | 5107 | 0.290 |
Why?
|
| Uterine Cervical Neoplasms | 4 | 2015 | 2043 | 0.280 |
Why?
|
| Sexual Behavior | 5 | 2021 | 2197 | 0.280 |
Why?
|
| Tissue Donors | 4 | 2005 | 2381 | 0.270 |
Why?
|
| Drug and Narcotic Control | 2 | 2005 | 145 | 0.270 |
Why?
|
| Ecology | 2 | 2005 | 105 | 0.270 |
Why?
|
| Congresses as Topic | 1 | 2012 | 812 | 0.270 |
Why?
|
| Wounds, Gunshot | 3 | 2017 | 587 | 0.270 |
Why?
|
| Anesthetics | 4 | 1993 | 525 | 0.270 |
Why?
|
| Breast | 1 | 2015 | 1976 | 0.270 |
Why?
|
| Social Behavior | 4 | 2021 | 1147 | 0.260 |
Why?
|
| Minority Groups | 4 | 2010 | 1216 | 0.260 |
Why?
|
| Risk Factors | 35 | 2021 | 74944 | 0.260 |
Why?
|
| Alcohol-Related Disorders | 1 | 2008 | 243 | 0.260 |
Why?
|
| Hydrogen-Ion Concentration | 5 | 2022 | 2486 | 0.260 |
Why?
|
| Sex Distribution | 8 | 2017 | 2278 | 0.250 |
Why?
|
| Public Policy | 3 | 2008 | 552 | 0.250 |
Why?
|
| Suicide | 1 | 2017 | 1606 | 0.250 |
Why?
|
| Hydroxyprogesterones | 2 | 1996 | 26 | 0.250 |
Why?
|
| Ecosystem | 1 | 2010 | 494 | 0.250 |
Why?
|
| Postal Service | 2 | 2003 | 96 | 0.250 |
Why?
|
| Budgets | 2 | 2022 | 232 | 0.250 |
Why?
|
| Self-Assessment | 2 | 2005 | 400 | 0.240 |
Why?
|
| Aged, 80 and over | 19 | 2024 | 59626 | 0.240 |
Why?
|
| Healthy People Programs | 1 | 2005 | 54 | 0.240 |
Why?
|
| Body Mass Index | 7 | 2023 | 13053 | 0.240 |
Why?
|
| Hypertension | 5 | 2015 | 8616 | 0.240 |
Why?
|
| Emigration and Immigration | 1 | 2007 | 406 | 0.230 |
Why?
|
| Forecasting | 5 | 2021 | 2945 | 0.230 |
Why?
|
| Progesterone | 5 | 1994 | 752 | 0.230 |
Why?
|
| Cohort Studies | 21 | 2020 | 41753 | 0.230 |
Why?
|
| Mesons | 3 | 2014 | 28 | 0.230 |
Why?
|
| Human Rights | 4 | 2015 | 312 | 0.230 |
Why?
|
| Sex Factors | 17 | 2014 | 10632 | 0.220 |
Why?
|
| Women | 2 | 1999 | 225 | 0.220 |
Why?
|
| Hormone Replacement Therapy | 2 | 2010 | 757 | 0.220 |
Why?
|
| Harm Reduction | 1 | 2005 | 143 | 0.220 |
Why?
|
| Scleroderma, Diffuse | 1 | 2023 | 18 | 0.220 |
Why?
|
| Histamine | 2 | 1996 | 496 | 0.220 |
Why?
|
| Lead Poisoning | 2 | 2003 | 323 | 0.220 |
Why?
|
| Calcitriol | 2 | 2014 | 303 | 0.220 |
Why?
|
| Bone Density | 2 | 2016 | 3573 | 0.220 |
Why?
|
| Liver Transplantation | 6 | 2005 | 2401 | 0.210 |
Why?
|
| History, 18th Century | 3 | 2019 | 206 | 0.210 |
Why?
|
| Databases, Factual | 7 | 2017 | 8080 | 0.210 |
Why?
|
| Blood Pressure | 5 | 2014 | 8543 | 0.210 |
Why?
|
| Wounds, Stab | 1 | 2003 | 72 | 0.210 |
Why?
|
| Rhode Island | 4 | 2005 | 352 | 0.210 |
Why?
|
| Sociology, Medical | 2 | 2012 | 62 | 0.210 |
Why?
|
| 3-Hydroxysteroid Dehydrogenases | 3 | 1989 | 34 | 0.210 |
Why?
|
| Scleroderma, Localized | 1 | 2023 | 85 | 0.200 |
Why?
|
| San Francisco | 6 | 2008 | 166 | 0.200 |
Why?
|
| Environmental Exposure | 5 | 2014 | 4543 | 0.200 |
Why?
|
| Pancreas Transplantation | 1 | 2003 | 193 | 0.200 |
Why?
|
| Pregnanediones | 2 | 1992 | 11 | 0.200 |
Why?
|
| Linear Models | 8 | 2013 | 5884 | 0.200 |
Why?
|
| Child | 27 | 2021 | 80917 | 0.200 |
Why?
|
| Hormones | 2 | 2022 | 866 | 0.200 |
Why?
|
| Environmental Medicine | 1 | 2001 | 15 | 0.190 |
Why?
|
| Maps as Topic | 1 | 2001 | 18 | 0.190 |
Why?
|
| Geography | 4 | 2005 | 652 | 0.190 |
Why?
|
| Age Distribution | 5 | 2017 | 2873 | 0.190 |
Why?
|
| Public Health Administration | 2 | 1996 | 242 | 0.190 |
Why?
|
| Reflex | 3 | 1992 | 375 | 0.190 |
Why?
|
| Social Desirability | 2 | 2011 | 45 | 0.190 |
Why?
|
| Environmental Health | 2 | 2003 | 298 | 0.190 |
Why?
|
| Chlorthalidone | 1 | 2021 | 21 | 0.190 |
Why?
|
| Rats, Inbred Strains | 12 | 1992 | 2087 | 0.180 |
Why?
|
| Rats | 22 | 2021 | 23782 | 0.180 |
Why?
|
| Life Expectancy | 2 | 2023 | 1248 | 0.180 |
Why?
|
| Illinois | 1 | 2021 | 120 | 0.180 |
Why?
|
| Delivery of Health Care | 3 | 2017 | 5367 | 0.180 |
Why?
|
| Health Care Reform | 1 | 2010 | 1256 | 0.180 |
Why?
|
| Bisexuality | 2 | 2015 | 295 | 0.180 |
Why?
|
| Calcium Oxalate | 1 | 2021 | 75 | 0.180 |
Why?
|
| Sexually Transmitted Diseases | 2 | 2003 | 668 | 0.170 |
Why?
|
| Health | 1 | 2003 | 398 | 0.170 |
Why?
|
| Heterosexuality | 2 | 2021 | 309 | 0.170 |
Why?
|
| Air Pollution | 1 | 2014 | 2374 | 0.170 |
Why?
|
| Mandatory Reporting | 1 | 2021 | 123 | 0.170 |
Why?
|
| Child, Preschool | 15 | 2020 | 42669 | 0.170 |
Why?
|
| Life Style | 4 | 2007 | 3932 | 0.170 |
Why?
|
| Young Adult | 13 | 2021 | 60066 | 0.170 |
Why?
|
| Scleroderma, Systemic | 1 | 2023 | 346 | 0.160 |
Why?
|
| Affinity Labels | 2 | 1996 | 107 | 0.160 |
Why?
|
| Vulnerable Populations | 1 | 2005 | 718 | 0.160 |
Why?
|
| Body Weight | 3 | 2016 | 4627 | 0.160 |
Why?
|
| Sexuality | 2 | 2014 | 179 | 0.160 |
Why?
|
| Cadaver | 1 | 2003 | 1364 | 0.160 |
Why?
|
| Water Purification | 1 | 2019 | 61 | 0.160 |
Why?
|
| Sanitation | 1 | 2019 | 83 | 0.160 |
Why?
|
| DNA Methylation | 2 | 2023 | 4428 | 0.150 |
Why?
|
| Living Donors | 1 | 2003 | 647 | 0.150 |
Why?
|
| Phosphates | 1 | 2022 | 765 | 0.150 |
Why?
|
| Pregnancy | 13 | 2020 | 30255 | 0.150 |
Why?
|
| Multivariate Analysis | 8 | 2013 | 12077 | 0.150 |
Why?
|
| Risk | 8 | 2015 | 9613 | 0.150 |
Why?
|
| Time Factors | 12 | 2020 | 40220 | 0.150 |
Why?
|
| Animals | 40 | 2022 | 169285 | 0.150 |
Why?
|
| Survival Analysis | 7 | 2020 | 10099 | 0.150 |
Why?
|
| Dengue | 1 | 2021 | 258 | 0.140 |
Why?
|
| Patient Selection | 2 | 2007 | 4260 | 0.140 |
Why?
|
| Prevalence | 11 | 2020 | 15869 | 0.140 |
Why?
|
| Models, Organizational | 1 | 2001 | 548 | 0.140 |
Why?
|
| Environment | 2 | 2021 | 1121 | 0.140 |
Why?
|
| Dopamine | 5 | 1984 | 1592 | 0.140 |
Why?
|
| Logistic Models | 6 | 2017 | 13290 | 0.140 |
Why?
|
| Paraffin Embedding | 1 | 2018 | 306 | 0.140 |
Why?
|
| Tissue Fixation | 1 | 2018 | 245 | 0.140 |
Why?
|
| Osteoclasts | 1 | 2020 | 713 | 0.140 |
Why?
|
| Emergency Service, Hospital | 1 | 2016 | 7951 | 0.140 |
Why?
|
| Policy | 1 | 2020 | 513 | 0.140 |
Why?
|
| Women's Rights | 1 | 1997 | 66 | 0.130 |
Why?
|
| Twins | 1 | 1998 | 341 | 0.130 |
Why?
|
| Steroids | 2 | 1992 | 938 | 0.130 |
Why?
|
| Mammals | 1 | 2022 | 1135 | 0.130 |
Why?
|
| Jurisprudence | 1 | 2016 | 109 | 0.130 |
Why?
|
| Skin Pigmentation | 1 | 1998 | 280 | 0.130 |
Why?
|
| Formaldehyde | 1 | 2018 | 361 | 0.130 |
Why?
|
| Women's Health Services | 1 | 1996 | 87 | 0.130 |
Why?
|
| Latin America | 2 | 2010 | 416 | 0.130 |
Why?
|
| Disease Outbreaks | 4 | 2021 | 1761 | 0.130 |
Why?
|
| Sickness Impact Profile | 1 | 2017 | 299 | 0.130 |
Why?
|
| Child Welfare | 1 | 2019 | 523 | 0.120 |
Why?
|
| Odds Ratio | 6 | 2017 | 9669 | 0.120 |
Why?
|
| Chromatography, Thin Layer | 5 | 1993 | 212 | 0.120 |
Why?
|
| Hodgkin Disease | 1 | 2003 | 1384 | 0.120 |
Why?
|
| Pregnant Women | 1 | 2020 | 576 | 0.120 |
Why?
|
| Progesterone-Binding Globulin | 1 | 1994 | 1 | 0.120 |
Why?
|
| Psychophysiologic Disorders | 1 | 1997 | 223 | 0.120 |
Why?
|
| Cardiovascular Diseases | 4 | 2020 | 15662 | 0.120 |
Why?
|
| Sociology | 3 | 2001 | 21 | 0.110 |
Why?
|
| Elementary Particles | 1 | 2014 | 50 | 0.110 |
Why?
|
| India | 1 | 2020 | 2334 | 0.110 |
Why?
|
| Bone and Bones | 2 | 2022 | 2590 | 0.110 |
Why?
|
| Tuberculosis, Pulmonary | 1 | 2001 | 843 | 0.110 |
Why?
|
| Quantum Theory | 1 | 2014 | 68 | 0.110 |
Why?
|
| Anesthesia, General | 2 | 1991 | 1189 | 0.110 |
Why?
|
| Electrons | 2 | 2014 | 264 | 0.110 |
Why?
|
| Religion | 1 | 2017 | 376 | 0.110 |
Why?
|
| Tuberculosis | 2 | 2003 | 2029 | 0.110 |
Why?
|
| X-Ray Microtomography | 1 | 2016 | 457 | 0.110 |
Why?
|
| Reflex, Abnormal | 1 | 1993 | 83 | 0.110 |
Why?
|
| Estradiol | 2 | 2001 | 1951 | 0.110 |
Why?
|
| Dinoprostone | 1 | 1996 | 597 | 0.110 |
Why?
|
| Homosexuality | 2 | 2010 | 269 | 0.110 |
Why?
|
| Anesthesia | 3 | 1993 | 1596 | 0.100 |
Why?
|
| Mice, Knockout | 2 | 2020 | 14488 | 0.100 |
Why?
|
| Brain | 10 | 1994 | 27362 | 0.100 |
Why?
|
| Gene Expression | 1 | 2005 | 7601 | 0.100 |
Why?
|
| Reproductive Health Services | 1 | 2013 | 90 | 0.100 |
Why?
|
| Alendronate | 1 | 2014 | 174 | 0.100 |
Why?
|
| Phenotype | 4 | 2016 | 16726 | 0.100 |
Why?
|
| Stomach Neoplasms | 1 | 2003 | 1481 | 0.100 |
Why?
|
| Cluster Analysis | 2 | 2020 | 2732 | 0.100 |
Why?
|
| Cultural Diversity | 1 | 1996 | 373 | 0.100 |
Why?
|
| Reference Standards | 3 | 2005 | 1014 | 0.100 |
Why?
|
| 3-Oxo-5-alpha-Steroid 4-Dehydrogenase | 2 | 1983 | 74 | 0.100 |
Why?
|
| Insecticides | 1 | 1994 | 200 | 0.100 |
Why?
|
| Nuclear Physics | 1 | 2012 | 73 | 0.100 |
Why?
|
| Kidney Diseases | 1 | 2003 | 2100 | 0.100 |
Why?
|
| Family | 1 | 2003 | 3209 | 0.100 |
Why?
|
| Chlamydia Infections | 1 | 1995 | 365 | 0.100 |
Why?
|
| Sampling Studies | 2 | 2008 | 615 | 0.100 |
Why?
|
| Vaginal Smears | 1 | 2015 | 505 | 0.100 |
Why?
|
| Thyrotropin-Releasing Hormone | 2 | 1982 | 139 | 0.100 |
Why?
|
| Los Angeles | 2 | 2011 | 245 | 0.100 |
Why?
|
| Supreme Court Decisions | 1 | 2013 | 135 | 0.100 |
Why?
|
| China | 1 | 2018 | 2395 | 0.100 |
Why?
|
| Developmental Biology | 1 | 2012 | 79 | 0.100 |
Why?
|
| Confidence Intervals | 2 | 2013 | 2923 | 0.100 |
Why?
|
| Glutamate Decarboxylase | 4 | 1985 | 239 | 0.100 |
Why?
|
| Metaphor | 1 | 2012 | 41 | 0.100 |
Why?
|
| Communication Barriers | 1 | 2015 | 419 | 0.100 |
Why?
|
| Mental Recall | 1 | 1998 | 1226 | 0.100 |
Why?
|
| Breast Diseases | 2 | 1992 | 442 | 0.090 |
Why?
|
| Obstetric Labor, Premature | 2 | 2004 | 268 | 0.090 |
Why?
|
| Body Image | 1 | 2016 | 646 | 0.090 |
Why?
|
| Gonorrhea | 1 | 1995 | 355 | 0.090 |
Why?
|
| Self Report | 3 | 2012 | 3773 | 0.090 |
Why?
|
| Homosexuality, Male | 2 | 1997 | 1344 | 0.090 |
Why?
|
| Calcium, Dietary | 1 | 2014 | 533 | 0.090 |
Why?
|
| Physics | 1 | 2011 | 92 | 0.090 |
Why?
|
| Postural Balance | 2 | 1992 | 639 | 0.090 |
Why?
|
| Health Priorities | 2 | 2012 | 380 | 0.090 |
Why?
|
| Marital Status | 2 | 2010 | 426 | 0.090 |
Why?
|
| Carrier Proteins | 2 | 1996 | 4939 | 0.090 |
Why?
|
| Occupational Diseases | 3 | 2007 | 1457 | 0.090 |
Why?
|
| Oxidoreductases | 2 | 1983 | 410 | 0.090 |
Why?
|
| Spectrum Analysis | 1 | 2012 | 449 | 0.090 |
Why?
|
| North America | 2 | 2012 | 1289 | 0.090 |
Why?
|
| Waist Circumference | 1 | 2014 | 935 | 0.090 |
Why?
|
| Carboxy-Lyases | 2 | 1981 | 85 | 0.090 |
Why?
|
| Fathers | 2 | 2006 | 377 | 0.080 |
Why?
|
| Safe Sex | 1 | 2010 | 144 | 0.080 |
Why?
|
| Perception | 1 | 2016 | 1209 | 0.080 |
Why?
|
| Bayes Theorem | 3 | 2021 | 2359 | 0.080 |
Why?
|
| Computer Simulation | 4 | 2023 | 6283 | 0.080 |
Why?
|
| Space-Time Clustering | 1 | 2008 | 45 | 0.080 |
Why?
|
| Analgesia | 1 | 1993 | 460 | 0.080 |
Why?
|
| Halothane | 1 | 1989 | 200 | 0.080 |
Why?
|
| Cerebellum | 1 | 1996 | 1522 | 0.080 |
Why?
|
| Precancerous Conditions | 1 | 2015 | 985 | 0.080 |
Why?
|
| Kidney | 3 | 2014 | 7064 | 0.080 |
Why?
|
| Condoms | 1 | 2010 | 337 | 0.080 |
Why?
|
| Culture | 2 | 2008 | 622 | 0.080 |
Why?
|
| Schools, Public Health | 1 | 1988 | 23 | 0.080 |
Why?
|
| Accidents, Occupational | 1 | 2010 | 251 | 0.080 |
Why?
|
| Health Behavior | 4 | 2008 | 2650 | 0.070 |
Why?
|
| Smoking Cessation | 2 | 2011 | 2085 | 0.070 |
Why?
|
| Unemployment | 2 | 2003 | 211 | 0.070 |
Why?
|
| Occupational Health Services | 1 | 2009 | 149 | 0.070 |
Why?
|
| Neoplasm Staging | 2 | 2020 | 11244 | 0.070 |
Why?
|
| Spouses | 1 | 2010 | 286 | 0.070 |
Why?
|
| Industry | 2 | 2010 | 362 | 0.070 |
Why?
|
| Physician-Patient Relations | 2 | 2015 | 3269 | 0.070 |
Why?
|
| Rana catesbeiana | 3 | 1992 | 85 | 0.070 |
Why?
|
| Risk Assessment | 8 | 2020 | 24318 | 0.070 |
Why?
|
| Mental Health | 2 | 2012 | 3275 | 0.070 |
Why?
|
| Graft Survival | 5 | 2005 | 3887 | 0.070 |
Why?
|
| Nonlinear Dynamics | 1 | 2010 | 493 | 0.070 |
Why?
|
| Cell Differentiation | 2 | 2020 | 11677 | 0.070 |
Why?
|
| Proportional Hazards Models | 5 | 2008 | 12543 | 0.070 |
Why?
|
| International Cooperation | 2 | 2003 | 1436 | 0.070 |
Why?
|
| Colorectal Neoplasms | 2 | 2018 | 6975 | 0.070 |
Why?
|
| Feasibility Studies | 3 | 2021 | 5315 | 0.070 |
Why?
|
| Ethanol | 1 | 1993 | 1331 | 0.070 |
Why?
|
| Evidence-Based Medicine | 2 | 2012 | 3706 | 0.070 |
Why?
|
| Qualitative Research | 3 | 2015 | 3140 | 0.070 |
Why?
|
| Costs and Cost Analysis | 2 | 2003 | 1667 | 0.070 |
Why?
|
| Medical Records | 1 | 1992 | 1410 | 0.070 |
Why?
|
| Bone Density Conservation Agents | 1 | 2014 | 797 | 0.070 |
Why?
|
| Ovariectomy | 1 | 1989 | 613 | 0.070 |
Why?
|
| Body Height | 1 | 2012 | 1565 | 0.070 |
Why?
|
| Financial Management | 1 | 1988 | 161 | 0.070 |
Why?
|
| Obesity | 2 | 2007 | 13091 | 0.070 |
Why?
|
| Delivery, Obstetric | 1 | 1993 | 954 | 0.060 |
Why?
|
| Regression Analysis | 3 | 2008 | 6340 | 0.060 |
Why?
|
| Tissue and Organ Procurement | 2 | 2005 | 986 | 0.060 |
Why?
|
| Education | 1 | 2009 | 533 | 0.060 |
Why?
|
| Coronary Disease | 2 | 1998 | 5919 | 0.060 |
Why?
|
| Sexual Partners | 1 | 2010 | 805 | 0.060 |
Why?
|
| Mice | 11 | 2020 | 82049 | 0.060 |
Why?
|
| Spinal Cord | 3 | 1985 | 1812 | 0.060 |
Why?
|
| Lead | 2 | 2003 | 882 | 0.060 |
Why?
|
| Resource Allocation | 1 | 1988 | 354 | 0.060 |
Why?
|
| Chronic Disease | 5 | 2020 | 9384 | 0.060 |
Why?
|
| Brain Death | 2 | 2005 | 359 | 0.060 |
Why?
|
| Child Abuse | 3 | 2004 | 1091 | 0.060 |
Why?
|
| Social Control, Formal | 1 | 2005 | 107 | 0.060 |
Why?
|
| Histocompatibility Antigens | 1 | 2006 | 479 | 0.060 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 1 | 2023 | 5717 | 0.060 |
Why?
|
| Twins, Dizygotic | 1 | 2005 | 236 | 0.060 |
Why?
|
| History, 17th Century | 2 | 2000 | 108 | 0.060 |
Why?
|
| Connecticut | 2 | 2003 | 366 | 0.060 |
Why?
|
| Graft Rejection | 4 | 2006 | 4492 | 0.060 |
Why?
|
| Information Dissemination | 2 | 2010 | 1143 | 0.060 |
Why?
|
| Financing, Government | 1 | 1988 | 473 | 0.060 |
Why?
|
| Sleep | 1 | 2020 | 4818 | 0.060 |
Why?
|
| Diabetes Mellitus | 3 | 2020 | 5891 | 0.060 |
Why?
|
| Kinetics | 6 | 1994 | 6330 | 0.060 |
Why?
|
| World Health Organization | 2 | 2008 | 1328 | 0.060 |
Why?
|
| Analysis of Variance | 2 | 2009 | 6229 | 0.060 |
Why?
|
| Genotype | 2 | 2016 | 13045 | 0.060 |
Why?
|
| Shame | 1 | 2004 | 80 | 0.060 |
Why?
|
| Absenteeism | 1 | 2005 | 247 | 0.060 |
Why?
|
| Progestins | 1 | 1985 | 302 | 0.060 |
Why?
|
| Digestive System Neoplasms | 1 | 2004 | 82 | 0.050 |
Why?
|
| Sodium-Calcium Exchanger | 2 | 1996 | 90 | 0.050 |
Why?
|
| Twins, Monozygotic | 1 | 2005 | 472 | 0.050 |
Why?
|
| Psychometrics | 2 | 2010 | 3063 | 0.050 |
Why?
|
| Perimenopause | 1 | 2004 | 142 | 0.050 |
Why?
|
| Salaries and Fringe Benefits | 1 | 2006 | 263 | 0.050 |
Why?
|
| Cells, Cultured | 3 | 2016 | 19025 | 0.050 |
Why?
|
| Preventive Medicine | 1 | 2005 | 246 | 0.050 |
Why?
|
| Patient Advocacy | 1 | 2005 | 362 | 0.050 |
Why?
|
| 3-alpha-Hydroxysteroid Dehydrogenase (B-Specific) | 3 | 1989 | 6 | 0.050 |
Why?
|
| Larva | 3 | 1992 | 515 | 0.050 |
Why?
|
| Career Mobility | 1 | 2005 | 262 | 0.050 |
Why?
|
| Climacteric | 1 | 2002 | 57 | 0.050 |
Why?
|
| Isoantigens | 1 | 2005 | 562 | 0.050 |
Why?
|
| Evaluation Studies as Topic | 2 | 2003 | 1627 | 0.050 |
Why?
|
| Cyclic AMP | 2 | 1984 | 1470 | 0.050 |
Why?
|
| Follow-Up Studies | 9 | 2021 | 39354 | 0.050 |
Why?
|
| Prognosis | 4 | 2016 | 30009 | 0.050 |
Why?
|
| Choline O-Acetyltransferase | 1 | 1983 | 156 | 0.050 |
Why?
|
| Intraocular Pressure | 1 | 1988 | 1304 | 0.050 |
Why?
|
| Reproducibility of Results | 5 | 2022 | 20225 | 0.050 |
Why?
|
| 5-alpha-Dihydroprogesterone | 2 | 1992 | 5 | 0.050 |
Why?
|
| Guidelines as Topic | 2 | 2000 | 1397 | 0.050 |
Why?
|
| Risk-Taking | 1 | 2008 | 1023 | 0.050 |
Why?
|
| Kidney Failure, Chronic | 2 | 2005 | 2496 | 0.050 |
Why?
|
| Receptors, CCR5 | 1 | 2004 | 491 | 0.050 |
Why?
|
| Narration | 1 | 2004 | 223 | 0.050 |
Why?
|
| Membrane Proteins | 2 | 1996 | 7876 | 0.050 |
Why?
|
| Anti-Bacterial Agents | 1 | 2020 | 7477 | 0.050 |
Why?
|
| Cultural Deprivation | 1 | 2001 | 13 | 0.050 |
Why?
|
| Pregnancy Outcome | 2 | 2001 | 2972 | 0.050 |
Why?
|
| Cell Proliferation | 2 | 2016 | 10478 | 0.050 |
Why?
|
| Iodine Radioisotopes | 2 | 1996 | 1034 | 0.050 |
Why?
|
| Rhinitis, Allergic, Seasonal | 1 | 2002 | 104 | 0.050 |
Why?
|
| Epitopes, T-Lymphocyte | 1 | 2005 | 827 | 0.050 |
Why?
|
| Receptors, Chemokine | 1 | 2004 | 652 | 0.050 |
Why?
|
| Databases as Topic | 1 | 2003 | 472 | 0.050 |
Why?
|
| Twin Studies as Topic | 1 | 2001 | 103 | 0.050 |
Why?
|
| Algorithms | 2 | 2016 | 14164 | 0.050 |
Why?
|
| Afferent Pathways | 1 | 1982 | 304 | 0.050 |
Why?
|
| Logic | 1 | 2001 | 40 | 0.050 |
Why?
|
| Death | 1 | 2005 | 683 | 0.050 |
Why?
|
| Child Abuse, Sexual | 1 | 2004 | 400 | 0.050 |
Why?
|
| Kainic Acid | 3 | 1989 | 203 | 0.040 |
Why?
|
| Postmenopause | 2 | 2008 | 2518 | 0.040 |
Why?
|
| Sample Size | 1 | 2004 | 846 | 0.040 |
Why?
|
| Mice, Inbred C57BL | 3 | 2016 | 22380 | 0.040 |
Why?
|
| Leadership | 1 | 1990 | 1397 | 0.040 |
Why?
|
| France | 3 | 2006 | 497 | 0.040 |
Why?
|
| gamma-Aminobutyric Acid | 2 | 1984 | 1141 | 0.040 |
Why?
|
| Thailand | 1 | 2021 | 288 | 0.040 |
Why?
|
| Tacrolimus | 1 | 2004 | 750 | 0.040 |
Why?
|
| Neoplasm Invasiveness | 1 | 2008 | 3620 | 0.040 |
Why?
|
| Poisson Distribution | 2 | 2005 | 506 | 0.040 |
Why?
|
| Models, Structural | 1 | 2020 | 340 | 0.040 |
Why?
|
| Psychology | 1 | 2002 | 353 | 0.040 |
Why?
|
| Precipitating Factors | 1 | 1999 | 51 | 0.040 |
Why?
|
| Receptors, CXCR4 | 1 | 2004 | 729 | 0.040 |
Why?
|
| Follicle Stimulating Hormone | 1 | 2001 | 727 | 0.040 |
Why?
|
| Musculoskeletal Diseases | 1 | 2005 | 599 | 0.040 |
Why?
|
| Drug Industry | 1 | 2005 | 791 | 0.040 |
Why?
|
| Diabetes Mellitus, Type 2 | 1 | 2023 | 12252 | 0.040 |
Why?
|
| Longitudinal Studies | 4 | 2023 | 14783 | 0.040 |
Why?
|
| Ciprofloxacin | 1 | 2020 | 313 | 0.040 |
Why?
|
| Nepal | 1 | 2019 | 301 | 0.040 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 2 | 1994 | 1730 | 0.040 |
Why?
|
| Chromatography, Gel | 2 | 1991 | 636 | 0.040 |
Why?
|
| Sodium | 2 | 1996 | 1597 | 0.040 |
Why?
|
| New England | 1 | 2001 | 1058 | 0.040 |
Why?
|
| Chromatography, High Pressure Liquid | 2 | 1993 | 1535 | 0.040 |
Why?
|
| Liver Neoplasms | 2 | 2004 | 4363 | 0.040 |
Why?
|
| South Africa | 1 | 2023 | 1873 | 0.040 |
Why?
|
| Social Change | 1 | 1998 | 152 | 0.040 |
Why?
|
| CpG Islands | 1 | 2022 | 1208 | 0.040 |
Why?
|
| Birth Certificates | 1 | 1997 | 71 | 0.040 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 11930 | 0.040 |
Why?
|
| Osteosarcoma | 2 | 1996 | 911 | 0.040 |
Why?
|
| Internet | 1 | 2009 | 3110 | 0.040 |
Why?
|
| Neuroendocrine Tumors | 1 | 2004 | 657 | 0.040 |
Why?
|
| Telomere | 1 | 2023 | 943 | 0.040 |
Why?
|
| Ovary | 1 | 2001 | 965 | 0.030 |
Why?
|
| National Health Programs | 2 | 1993 | 442 | 0.030 |
Why?
|
| Immunosuppressive Agents | 3 | 2004 | 4206 | 0.030 |
Why?
|
| Health Promotion | 1 | 2009 | 2210 | 0.030 |
Why?
|
| Biopsy | 2 | 2003 | 6792 | 0.030 |
Why?
|
| Receptors, Estradiol | 1 | 1996 | 18 | 0.030 |
Why?
|
| Liver | 3 | 2004 | 7578 | 0.030 |
Why?
|
| RNA, Ribosomal, 16S | 1 | 2020 | 1049 | 0.030 |
Why?
|
| Rehabilitation, Vocational | 1 | 1976 | 70 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2005 | 2507 | 0.030 |
Why?
|
| Death, Sudden, Cardiac | 1 | 2004 | 1567 | 0.030 |
Why?
|
| Pancreas | 1 | 2003 | 1699 | 0.030 |
Why?
|
| Anti-Inflammatory Agents | 1 | 1985 | 1810 | 0.030 |
Why?
|
| Tumor Cells, Cultured | 2 | 1996 | 6124 | 0.030 |
Why?
|
| Anger | 1 | 1998 | 405 | 0.030 |
Why?
|
| Cell Membrane | 2 | 1996 | 3655 | 0.030 |
Why?
|
| Mothers | 1 | 2006 | 2209 | 0.030 |
Why?
|
| Cholesterol, LDL | 1 | 2005 | 2403 | 0.030 |
Why?
|
| Laxatives | 1 | 2016 | 95 | 0.030 |
Why?
|
| Estrogen Antagonists | 1 | 1996 | 151 | 0.030 |
Why?
|
| Cell Movement | 2 | 2005 | 5213 | 0.030 |
Why?
|
| Heart Transplantation | 2 | 2006 | 3301 | 0.030 |
Why?
|
| Predictive Value of Tests | 2 | 2009 | 15453 | 0.030 |
Why?
|
| Fear | 1 | 2004 | 1493 | 0.030 |
Why?
|
| Wisconsin | 2 | 2005 | 122 | 0.030 |
Why?
|
| Mice, Inbred CBA | 2 | 2006 | 439 | 0.030 |
Why?
|
| Autoimmunity | 1 | 2023 | 1361 | 0.030 |
Why?
|
| Dendritic Cells | 1 | 2006 | 2747 | 0.030 |
Why?
|
| Epidemics | 1 | 2021 | 517 | 0.030 |
Why?
|
| Prospective Studies | 7 | 2018 | 54924 | 0.030 |
Why?
|
| Travel | 1 | 2021 | 805 | 0.030 |
Why?
|
| Tissue Preservation | 2 | 2005 | 173 | 0.030 |
Why?
|
| Philosophy, Medical | 1 | 1994 | 78 | 0.030 |
Why?
|
| Transplantation, Homologous | 1 | 2003 | 4834 | 0.030 |
Why?
|
| Depression | 2 | 2012 | 8230 | 0.030 |
Why?
|
| Dihydrotestosterone | 2 | 1985 | 195 | 0.030 |
Why?
|
| Communicable Disease Control | 1 | 2001 | 857 | 0.030 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 1 | 2022 | 3806 | 0.030 |
Why?
|
| Immune Tolerance | 1 | 2023 | 2323 | 0.030 |
Why?
|
| Attitude of Health Personnel | 3 | 2015 | 3929 | 0.030 |
Why?
|
| Dichlorodiphenyl Dichloroethylene | 1 | 1994 | 85 | 0.030 |
Why?
|
| Bulimia | 1 | 2016 | 405 | 0.030 |
Why?
|
| Health Education | 2 | 1993 | 1059 | 0.030 |
Why?
|
| Feces | 1 | 2020 | 1511 | 0.030 |
Why?
|
| Autoradiography | 1 | 1994 | 728 | 0.030 |
Why?
|
| Molecular Weight | 1 | 1996 | 2173 | 0.030 |
Why?
|
| CD4-Positive T-Lymphocytes | 1 | 2006 | 4415 | 0.030 |
Why?
|
| Patient Compliance | 1 | 2004 | 2697 | 0.030 |
Why?
|
| Lymph Nodes | 1 | 2005 | 3474 | 0.030 |
Why?
|
| Extraction, Obstetrical | 1 | 1993 | 28 | 0.030 |
Why?
|
| Scotland | 1 | 1993 | 142 | 0.030 |
Why?
|
| Statistics as Topic | 1 | 2000 | 2357 | 0.030 |
Why?
|
| Interviews as Topic | 2 | 2012 | 2741 | 0.030 |
Why?
|
| HIV Infections | 2 | 2016 | 17569 | 0.030 |
Why?
|
| Frontal Lobe | 1 | 1979 | 1426 | 0.030 |
Why?
|
| Binding, Competitive | 1 | 1994 | 1142 | 0.030 |
Why?
|
| Hospitals, University | 2 | 2005 | 570 | 0.030 |
Why?
|
| Internationality | 1 | 1998 | 1008 | 0.030 |
Why?
|
| Survival Rate | 2 | 2018 | 12840 | 0.030 |
Why?
|
| Intestinal Absorption | 1 | 2014 | 401 | 0.030 |
Why?
|
| Fracture Fixation, Intramedullary | 1 | 1975 | 160 | 0.030 |
Why?
|
| Tissue Distribution | 2 | 1989 | 2300 | 0.030 |
Why?
|
| Administration, Oral | 1 | 2020 | 4034 | 0.030 |
Why?
|
| Sex Education | 1 | 1993 | 94 | 0.030 |
Why?
|
| Polychlorinated Biphenyls | 1 | 1994 | 235 | 0.020 |
Why?
|
| Particle Accelerators | 1 | 2012 | 173 | 0.020 |
Why?
|
| Cholesterol, HDL | 1 | 1998 | 1820 | 0.020 |
Why?
|
| Tamoxifen | 1 | 1996 | 966 | 0.020 |
Why?
|
| Acute Kidney Injury | 1 | 2004 | 1942 | 0.020 |
Why?
|
| National Institutes of Health (U.S.) | 1 | 1995 | 794 | 0.020 |
Why?
|
| T-Lymphocytes, Regulatory | 1 | 2005 | 3115 | 0.020 |
Why?
|
| Carcinoma, Hepatocellular | 1 | 2004 | 2334 | 0.020 |
Why?
|
| Tritium | 1 | 1991 | 707 | 0.020 |
Why?
|
| Cuba | 1 | 1991 | 48 | 0.020 |
Why?
|
| Organ Specificity | 1 | 1996 | 1968 | 0.020 |
Why?
|
| Disease Models, Animal | 3 | 2020 | 18349 | 0.020 |
Why?
|
| Skin | 2 | 2023 | 4505 | 0.020 |
Why?
|
| Personal Autonomy | 1 | 1993 | 315 | 0.020 |
Why?
|
| Femoral Fractures | 1 | 1975 | 376 | 0.020 |
Why?
|
| Breast Feeding | 1 | 2019 | 1363 | 0.020 |
Why?
|
| Mass Screening | 2 | 2015 | 5458 | 0.020 |
Why?
|
| Receptors, Dopamine | 2 | 1982 | 293 | 0.020 |
Why?
|
| Fasting | 1 | 2016 | 1610 | 0.020 |
Why?
|
| Menopause | 1 | 1998 | 1656 | 0.020 |
Why?
|
| Coronary Artery Disease | 1 | 2010 | 6568 | 0.020 |
Why?
|
| Domestic Violence | 2 | 2001 | 180 | 0.020 |
Why?
|
| Philosophy | 1 | 1990 | 69 | 0.020 |
Why?
|
| Diagnosis, Differential | 1 | 2005 | 13013 | 0.020 |
Why?
|
| Complementary Therapies | 1 | 1993 | 487 | 0.020 |
Why?
|
| Capacity Building | 1 | 2012 | 265 | 0.020 |
Why?
|
| Case-Control Studies | 5 | 2001 | 22290 | 0.020 |
Why?
|
| Carcinogens, Environmental | 1 | 1989 | 70 | 0.020 |
Why?
|
| Kidney Transplantation | 1 | 2004 | 4262 | 0.020 |
Why?
|
| Trifluoperazine | 2 | 1979 | 40 | 0.020 |
Why?
|
| Estrogens | 1 | 1996 | 1536 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2020 | 6525 | 0.020 |
Why?
|
| Drug Synergism | 1 | 1993 | 1760 | 0.020 |
Why?
|
| Oklahoma | 1 | 1988 | 36 | 0.020 |
Why?
|
| Sex Offenses | 2 | 2004 | 357 | 0.020 |
Why?
|
| Severity of Illness Index | 2 | 2020 | 15949 | 0.020 |
Why?
|
| Focus Groups | 1 | 2015 | 1460 | 0.020 |
Why?
|
| Depressive Disorder | 1 | 2001 | 3721 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2011 | 994 | 0.020 |
Why?
|
| Biometry | 1 | 2011 | 570 | 0.020 |
Why?
|
| Health Occupations | 1 | 1990 | 225 | 0.020 |
Why?
|
| Disease | 1 | 1993 | 675 | 0.020 |
Why?
|
| DNA-Binding Proteins | 1 | 2005 | 9617 | 0.020 |
Why?
|
| Health Care Surveys | 1 | 2015 | 2434 | 0.020 |
Why?
|
| Colonic Neoplasms | 1 | 1999 | 2541 | 0.020 |
Why?
|
| United States Dept. of Health and Human Services | 1 | 1988 | 88 | 0.020 |
Why?
|
| Binding Sites | 1 | 1996 | 6019 | 0.020 |
Why?
|
| Molecular Structure | 1 | 1991 | 1884 | 0.020 |
Why?
|
| Microscopy, Fluorescence | 2 | 2006 | 2634 | 0.020 |
Why?
|
| Social Mobility | 1 | 2006 | 30 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 2 | 2006 | 6231 | 0.020 |
Why?
|
| Contraceptives, Oral | 1 | 1989 | 560 | 0.020 |
Why?
|
| T-Lymphocytes | 1 | 2004 | 10266 | 0.020 |
Why?
|
| Brazil | 1 | 1991 | 1250 | 0.020 |
Why?
|
| Hypothalamus | 2 | 1982 | 1004 | 0.020 |
Why?
|
| Hot Temperature | 1 | 1993 | 1440 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 2 | 1991 | 10763 | 0.020 |
Why?
|
| Developing Countries | 1 | 2019 | 2910 | 0.020 |
Why?
|
| Psychosocial Deprivation | 1 | 2006 | 101 | 0.020 |
Why?
|
| Medroxyprogesterone | 1 | 1985 | 34 | 0.020 |
Why?
|
| Treatment Outcome | 4 | 2009 | 65379 | 0.020 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2004 | 9419 | 0.020 |
Why?
|
| Cross-Cultural Comparison | 1 | 2009 | 638 | 0.020 |
Why?
|
| Biomedical Research | 2 | 1993 | 3463 | 0.020 |
Why?
|
| Sodium Glutamate | 1 | 1984 | 22 | 0.020 |
Why?
|
| Indomethacin | 1 | 1985 | 323 | 0.020 |
Why?
|
| Receptors, Lymphocyte Homing | 1 | 2005 | 141 | 0.020 |
Why?
|
| Medroxyprogesterone Acetate | 1 | 1985 | 155 | 0.020 |
Why?
|
| Postoperative Complications | 2 | 2005 | 15833 | 0.010 |
Why?
|
| Spinal Nerves | 1 | 1985 | 92 | 0.010 |
Why?
|
| Maternal Age | 1 | 1988 | 805 | 0.010 |
Why?
|
| Prenatal Care | 1 | 2012 | 1162 | 0.010 |
Why?
|
| Radioimmunoassay | 2 | 1985 | 863 | 0.010 |
Why?
|
| Biliary Tract Diseases | 1 | 2005 | 159 | 0.010 |
Why?
|
| Receptors, Lysophospholipid | 1 | 2004 | 40 | 0.010 |
Why?
|
| Clonal Anergy | 1 | 2005 | 169 | 0.010 |
Why?
|
| Chromatography, Affinity | 1 | 1985 | 525 | 0.010 |
Why?
|
| Carbachol | 1 | 1984 | 223 | 0.010 |
Why?
|
| Cesarean Section | 1 | 1993 | 1425 | 0.010 |
Why?
|
| Quality Improvement | 1 | 2019 | 3857 | 0.010 |
Why?
|
| Observer Variation | 1 | 2010 | 2621 | 0.010 |
Why?
|
| Propylene Glycols | 1 | 2004 | 91 | 0.010 |
Why?
|
| Receptors, CCR7 | 1 | 2004 | 105 | 0.010 |
Why?
|
| Abortion, Spontaneous | 1 | 1989 | 535 | 0.010 |
Why?
|
| Vitamin D | 1 | 1998 | 3311 | 0.010 |
Why?
|
| Feeding Behavior | 1 | 2016 | 3205 | 0.010 |
Why?
|
| Microinjections | 1 | 1984 | 322 | 0.010 |
Why?
|
| Substance P | 1 | 1985 | 332 | 0.010 |
Why?
|
| Behavior, Animal | 1 | 1992 | 1862 | 0.010 |
Why?
|
| Arachidonate 5-Lipoxygenase | 1 | 2004 | 128 | 0.010 |
Why?
|
| Enzyme Activation | 2 | 1980 | 3590 | 0.010 |
Why?
|
| Receptors, Leukotriene | 1 | 2004 | 97 | 0.010 |
Why?
|
| Cognition | 1 | 2021 | 7073 | 0.010 |
Why?
|
| Receptors, Interleukin-2 | 1 | 2005 | 564 | 0.010 |
Why?
|
| Analgesics | 1 | 1990 | 1071 | 0.010 |
Why?
|
| Communicable Diseases | 1 | 1992 | 873 | 0.010 |
Why?
|
| Receptors, CCR2 | 1 | 2004 | 216 | 0.010 |
Why?
|
| Myocardium | 1 | 1996 | 4790 | 0.010 |
Why?
|
| Asthma | 1 | 2002 | 6291 | 0.010 |
Why?
|
| Portal Vein | 1 | 2005 | 435 | 0.010 |
Why?
|
| Self Administration | 1 | 2004 | 386 | 0.010 |
Why?
|
| Intestinal Mucosa | 1 | 2014 | 3044 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2014 | 8142 | 0.010 |
Why?
|
| Carbon Radioisotopes | 1 | 1984 | 567 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1983 | 278 | 0.010 |
Why?
|
| Secondary Prevention | 1 | 2009 | 1474 | 0.010 |
Why?
|
| Cytosol | 1 | 1985 | 887 | 0.010 |
Why?
|
| Olfactory Mucosa | 1 | 1983 | 101 | 0.010 |
Why?
|
| Hydroxydopamines | 1 | 1982 | 59 | 0.010 |
Why?
|
| Rabbits | 1 | 1989 | 4773 | 0.010 |
Why?
|
| Ganglia, Spinal | 1 | 1985 | 529 | 0.010 |
Why?
|
| Freezing | 1 | 1983 | 311 | 0.010 |
Why?
|
| Sphingosine | 1 | 2004 | 308 | 0.010 |
Why?
|
| Castration | 1 | 1982 | 149 | 0.010 |
Why?
|
| Norepinephrine | 1 | 1984 | 898 | 0.010 |
Why?
|
| Oxidopamine | 1 | 1982 | 169 | 0.010 |
Why?
|
| Histocytochemistry | 1 | 1983 | 699 | 0.010 |
Why?
|
| Kidney Function Tests | 1 | 2004 | 684 | 0.010 |
Why?
|
| Motor Activity | 1 | 1991 | 2711 | 0.010 |
Why?
|
| Reproductive History | 1 | 2002 | 210 | 0.010 |
Why?
|
| Quality of Life | 1 | 2023 | 13490 | 0.010 |
Why?
|
| Tissue and Organ Harvesting | 1 | 2004 | 373 | 0.010 |
Why?
|
| Denervation | 1 | 1982 | 265 | 0.010 |
Why?
|
| Retrospective Studies | 6 | 2005 | 81760 | 0.010 |
Why?
|
| Cyclosporine | 1 | 2004 | 777 | 0.010 |
Why?
|
| Sexual Behavior, Animal | 1 | 1982 | 120 | 0.010 |
Why?
|
| Lampreys | 1 | 1981 | 32 | 0.010 |
Why?
|
| Menstrual Cycle | 1 | 2004 | 546 | 0.010 |
Why?
|
| Crystallization | 1 | 1982 | 520 | 0.010 |
Why?
|
| Treatment Refusal | 1 | 2004 | 433 | 0.010 |
Why?
|
| Anti-Anxiety Agents | 1 | 1983 | 405 | 0.010 |
Why?
|
| Immunophenotyping | 1 | 2005 | 1864 | 0.010 |
Why?
|
| Hepatectomy | 1 | 2004 | 588 | 0.010 |
Why?
|
| Substance-Related Disorders | 1 | 1997 | 4423 | 0.010 |
Why?
|
| Transplantation Tolerance | 1 | 2005 | 633 | 0.010 |
Why?
|
| Xenopus | 1 | 1982 | 711 | 0.010 |
Why?
|
| Statistics, Nonparametric | 1 | 2005 | 2862 | 0.010 |
Why?
|
| Population Density | 1 | 2000 | 193 | 0.010 |
Why?
|
| Early Detection of Cancer | 1 | 2014 | 3239 | 0.010 |
Why?
|
| Corticotropin-Releasing Hormone | 1 | 2001 | 361 | 0.010 |
Why?
|
| Microscopy, Electron | 1 | 1983 | 2560 | 0.010 |
Why?
|
| Patient Acceptance of Health Care | 1 | 2013 | 3231 | 0.010 |
Why?
|
| Nephrectomy | 1 | 2004 | 930 | 0.010 |
Why?
|
| Ambulatory Care Facilities | 1 | 2005 | 939 | 0.010 |
Why?
|
| Workload | 1 | 2005 | 849 | 0.010 |
Why?
|
| Coronary Circulation | 1 | 2005 | 1617 | 0.010 |
Why?
|
| Health Knowledge, Attitudes, Practice | 1 | 1994 | 4055 | 0.010 |
Why?
|
| Quality of Health Care | 1 | 1993 | 4310 | 0.010 |
Why?
|
| Creatinine | 1 | 2004 | 1918 | 0.010 |
Why?
|
| Forkhead Transcription Factors | 1 | 2005 | 1625 | 0.010 |
Why?
|
| Medical Record Linkage | 1 | 1999 | 286 | 0.010 |
Why?
|
| Matched-Pair Analysis | 1 | 1998 | 285 | 0.010 |
Why?
|
| Ligands | 1 | 2004 | 3284 | 0.010 |
Why?
|
| Prostatic Neoplasms | 1 | 1999 | 11101 | 0.010 |
Why?
|
| Pilot Projects | 1 | 1990 | 8741 | 0.010 |
Why?
|
| Neuroglia | 1 | 1982 | 960 | 0.010 |
Why?
|
| Venous Thrombosis | 1 | 2005 | 1321 | 0.010 |
Why?
|
| Flow Cytometry | 1 | 2006 | 5902 | 0.010 |
Why?
|
| Propranolol | 1 | 1977 | 493 | 0.010 |
Why?
|
| Lung Neoplasms | 1 | 1999 | 13586 | 0.010 |
Why?
|
| Pseudarthrosis | 1 | 1975 | 54 | 0.010 |
Why?
|
| Rehabilitation Centers | 1 | 1976 | 249 | 0.010 |
Why?
|
| Melanoma | 1 | 1993 | 5706 | 0.010 |
Why?
|
| Blood Glucose | 1 | 1988 | 6431 | 0.010 |
Why?
|
| Survivors | 1 | 2004 | 2381 | 0.010 |
Why?
|
| Bone Nails | 1 | 1975 | 221 | 0.010 |
Why?
|
| Reoperation | 1 | 2004 | 4329 | 0.010 |
Why?
|
| Skin Neoplasms | 1 | 1993 | 5863 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2006 | 11095 | 0.010 |
Why?
|
| Alcohol Drinking | 1 | 2005 | 4045 | 0.010 |
Why?
|
| Caregivers | 1 | 2004 | 2302 | 0.010 |
Why?
|
| Infant, Premature | 1 | 2001 | 2123 | 0.010 |
Why?
|
| Neurons | 2 | 1982 | 9514 | 0.010 |
Why?
|
| Antipsychotic Agents | 1 | 1983 | 3081 | 0.010 |
Why?
|
| Physicians | 1 | 1987 | 4598 | 0.000 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2005 | 10397 | 0.000 |
Why?
|
| Transcription Factors | 1 | 2005 | 12171 | 0.000 |
Why?
|
| Brain Mapping | 1 | 1980 | 6684 | 0.000 |
Why?
|
| Cats | 1 | 1985 | 978 | 0.000 |
Why?
|
| Cell Count | 1 | 1985 | 1832 | 0.000 |
Why?
|
| Cell Survival | 1 | 1985 | 5789 | 0.000 |
Why?
|